Latest Breaking News On - Discuss fourth quarter - Page 1 : comparemela.com

Douglas Elliman Inc Reports Fourth Quarter and Full Year 2023 Financial Results

Fourth Quarter 2023 Highlights: Revenues of $214.1 million, compared to $207.3 million in the prior year quarter Douglas Elliman’s real estate brokerage segment’s gross transaction value.

United statesNew yorkHowardm lorberDouglas ellimanDouglas elliman realtyDouglas elliman incFinancial measures of the companyChief executive officerNet lossDiscuss fourth quarterFull yearAdjusted netAnnual reportExcept per share amountsTax disaffiliationGross transaction value

BWX Technologies Reports Fourth Quarter and Full Year 2023 Results, Initiates 2024 Guidance

4Q23 diluted GAAP EPS of $0.72, diluted non-GAAP EPS of $1.01, on revenue of $725.5 million 4Q23 net income of $66.3 million, adjusted EBITDA of $147.6 million 2023 diluted GAAP EPS of $2.68,.

United statesRexd gevedenUs department of energyTechnologies incExchange commissionMonths ended decemberEnded decemberNot meaningfulFinancial results summaryOperating cash flowNet cash providedOperating activitiesCapital expendituresShare repurchasesCommon stockDividends paid

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomMatt crensonIan karpAlina liJohn leonardCompany progressEuropean commissionHealth care conferenceEuropean medicines agencyRegeneron pharmaceuticals incCompany at the marketExchange commissionCorporate communicationsRecode therapeutics incVivo program updates

Barings BDC, Inc Reports Fourth Quarter and Full Year 2023 Results and Announces Quarterly Cash Dividend of $0 26 Per Share

Barings BDC, Inc. today reported its financial and operating results for the fourth quarter and full year of 2023 and announced that the Company’s Board of Directors declared a quarterly cash.

United statesEric lloydElizabeth murrayAsia pacificShare repurchase programExchange commissionBarings bdc incSecurities exchangeInvestment companyCompany board of directors theChief executive officerChief financial officerInvestor relationsDiscuss fourth quarterFull yearFinancial condition

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update

Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United kingdomBritish columbiaJodi regtsXenon pharmaceuticalsXenon pharmaceuticals incXenon pharmaceuticals announces conference callPharmaceuticals announces conference callDiscuss fourth quarterFull yearProvide corporateWebcast informationEastern timePacific timeMedia contact